Detalhe da pesquisa
1.
Socioeconomic inequality in prostate cancer diagnostics, primary treatment, rehabilitation, and mortality in Sweden.
Int J Cancer
; 155(4): 637-645, 2024 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38526118
2.
Ki67 and prostate specific antigen are prognostic in metastatic hormone naïve prostate cancer.
Acta Oncol
; 62(12): 1698-1706, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37713321
3.
Risk of severe late toxicity after radiotherapy following radical prostatectomy - a nationwide study.
BJU Int
; 130(6): 799-808, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35523728
4.
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.
Lancet Oncol
; 22(2): 235-245, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33444529
5.
Deep learning-based classification and structure name standardization for organ at risk and target delineations in prostate cancer radiotherapy.
J Appl Clin Med Phys
; 22(12): 51-63, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34623738
6.
Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens.
Prostate
; 80(2): 214-224, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31799745
7.
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
Lancet
; 394(10196): 385-395, 2019 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31227373
8.
Re-treatment with radium-223: 2-year follow-up from an international, open-label, phase 1/2 study in patients with castration-resistant prostate cancer and bone metastases.
Prostate
; 79(14): 1683-1691, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31442327
9.
Platelets harbor prostate cancer biomarkers and the ability to predict therapeutic response to abiraterone in castration resistant patients.
Prostate
; 78(1): 48-53, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29094381
10.
U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.
Acta Oncol
; 57(2): 187-194, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28631533
11.
Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study.
Acta Oncol
; 61(3): 328-332, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34979865
12.
[Drastic changes in the treatment of metastatic prostate cancer]. / Behandling av metastaserad prostatacancer.
Lakartidningen
; 1212024 Apr 23.
Artigo
em Sueco
| MEDLINE | ID: mdl-38651316
13.
Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden.
Scand J Urol
; 582023 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37953522
14.
Hyaluronic acid spacer in prostate cancer radiotherapy: dosimetric effects, spacer stability and long-term toxicity and PRO in a phase II study.
Radiat Oncol
; 18(1): 1, 2023 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36593460
15.
A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases.
Eur J Cancer
; 181: 198-207, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36682096
16.
Histopathology-validated lesion detection rates of clinically significant prostate cancer with mpMRI, [ 68 Ga]PSMA-11-PET and [ 11 C]Acetate-PET.
Nucl Med Commun
; 44(11): 997-1004, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37615497
17.
The Swedish national guidelines on prostate cancer, part 1: early detection, diagnostics, staging, patient support and primary management of non-metastatic disease.
Scand J Urol
; 56(4): 265-273, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35811480
18.
Health-related Quality of Life in Intermediate- or High-risk Patients Treated With Radical External Radiotherapy and Adjuvant Docetaxel for Localized Prostate Cancer: A Randomized, Phase III SPCG-13 Study.
Anticancer Res
; 42(1): 87-92, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34969712
19.
Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C.
Mol Oncol
; 16(4): 846-859, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34889043
20.
Characteristics of Patients in SPCG-15-A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer.
Eur Urol Open Sci
; 41: 63-73, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35813256